Zobrazeno 1 - 2
of 2
pro vyhledávání: '"J. R. Furundarena Salsamendi"'
Autor:
J. A. Valero Jaimes, A. De Diego, C.A. Egües Dubuc, J. Calvo, O. Maiz-Alonso, J. R. Furundarena Salsamendi, L. M. Lopez Dominguez, P. Cabrera Miranda, J. M. Belzunegui Otano, J. J. Cancio Fanlo, E. Uriarte Isacelaya, N. Alcorta Lorenzo
Publikováno v:
Annals of the Rheumatic Diseases. 79:837.2-838
Background:The Hemophagocytic Syndrome (HPS) is has been classified into 2 groups: primary and secondary. The secondary form is mainly associated with hemato-oncological diseases (HOD) and autoimmune diseases (AID). The present work aims to obtain cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0b1198ad74e1388c9e8e4f585ac2540
https://doi.org/10.1136/annrheumdis-2020-eular.4688
https://doi.org/10.1136/annrheumdis-2020-eular.4688
Autor:
P. Cabrera Miranda, O. Maiz-Alonso, A. De Diego, N. Alcorta Lorenzo, E. Uriarte Isacelaya, C.A. Egües Dubuc, J. M. Belzunegui Otano, J. J. Cancio Fanlo, J. A. Valero Jaimes, J. Calvo, L. M. Lopez Dominguez, J. R. Furundarena Salsamendi
Publikováno v:
Annals of the Rheumatic Diseases. 79:1214.2-1214
Background:The Hemophagocytic Syndrome (HPS) had a mortality rate between 20% and 90%. The mortality of HPS secondary to autoimmune diseases (AID) is lower than hemato-oncological diseases (HOD). In general, the HOD, thrombocytopenia, age, and a prol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3619913b7453119228133e5175dec8eb
https://doi.org/10.1136/annrheumdis-2020-eular.5855
https://doi.org/10.1136/annrheumdis-2020-eular.5855